Song et al. [26] demonstrated that PRMT1 expression promoted the growth of pancreatic cancer-derived cells both in vitro and in vivo and is significantly correlated with pancreatic ductal adenocarcinoma tumor size and prognosis in postoperative patients. The gene discussed is PRMT1; the disease is familial pancreatic carcinoma.